Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
Authors
Henit Yanai,
Lev LichtensteinAmit Assa,
Yoav Mazor,
Batia Weiss,
Arie Levine,
Yulia Ron,
Uri Kopylov,
Yoram Bujanover,
Yoram Rosenbach,
Bella Ungar,
Rami Eliakim,
Yehuda Chowers,
Raanan Shamir,
Gerald Fraser,
Iris Dotan +14 authors
,
Shomron Ben‐Horin Tip Tip